search
Back to results

Improving SWAllowing After Stroke With Transcranial Direct Current Stimulation (iSWAT)

Primary Purpose

Acute Stroke, Dysphagia

Status
Terminated
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
transcranial direct current stimulation (tDCS)
Sponsored by
University Hospital of Mont-Godinne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Stroke

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

- acute stroke (ischemic / hemorrhagic) with dysphagia

Exclusion Criteria:

  • major swallowing impairment before the stroke
  • troubles of comprehension impairing communication
  • major cognitive dysfunction, neuro-degenerative disease, or major psychiatric condition (e.g. depression, Alzheimer's disease, …)
  • very unstable health issue (e.g. severe cardiac dyscfct, end-stage renal failure, unstable diabetes, …)
  • intracranial metal and/or devices excluding tDCS application
  • chronic intake of major drugs modifying brain activity (e.g. AEDs, antipsychotics)
  • regular use of alcohol or recreative drugs
  • epilepsy
  • pregnancy

Sites / Locations

  • University Hospital of Mont-Godinne : CHU Mont-Godinne UCL

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

real tDCS

sham tDCS

Arm Description

patients will receive non-invasive and painless brain stimulation over the rain areas involved in swallowing. tDCS will be applied during swallowing therapy, during 20 minutes

this will be exactly as for "real tDCS" unless that the tDCS will be rapidly turned off, unbeknown from patients-therapist-examinator (double-blind trial)

Outcomes

Primary Outcome Measures

VideoFluoroscopy (VFSS)
The patients will be asked to swallow radiocontrast agent liquid during RX (radiography) video-recording. The speed of swallowing, whether there is aspiration or stasis will be quantified off-line on videotape
Fiberoptic Endoscopic Evaluation of Swallowing (FEES)
A laryngoscope (attached to a camera and a color monitor) will be passed through the nostril. The patients will be asked to swallow small quantities of liquids and foods, and the quality of swallowing will be assessed off-line (videotaped examination). The base of the tongue, pharynx and larynx will be viewed.

Secondary Outcome Measures

NIH Stroke Scale
The NIS Stroke Scale is a clinical scale developped to score the severity of acute stroke. Patients will be asked to make some movements, vision will be tested, whether there are difficult to speak and so on.
clinical record
the records of the acute stroke patients will be used to search for relevant clinical events.
quality-of-life (QOL) questionnaire designed for dysphagia (SWAL-QOL)
A quality-of-life (QOL) questionnaire specifically designed for patients with oropharyngeal dysphagia (SWAL-QOL) will be used, questions will be asked to the patients / proxies? The French version of the SWAL-QOL will be used

Full Information

First Posted
December 27, 2012
Last Updated
May 8, 2023
Sponsor
University Hospital of Mont-Godinne
Collaborators
Université Catholique de Louvain
search

1. Study Identification

Unique Protocol Identification Number
NCT01758991
Brief Title
Improving SWAllowing After Stroke With Transcranial Direct Current Stimulation
Acronym
iSWAT
Official Title
Therapeutic Impact of tDCS on Dysphagia in the Acute Phase of Stroke / Impact thérapeutique de la tDCS Sur la Dysphagie en Phase Aigue de l'Accident Vasculaire cérébral
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Terminated
Why Stopped
lack of recruitment
Study Start Date
January 2013 (undefined)
Primary Completion Date
May 8, 2023 (Actual)
Study Completion Date
May 8, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital of Mont-Godinne
Collaborators
Université Catholique de Louvain

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
In the acute phase of stroke, dysphagia (difficulty/inability to swallow) is a common problem that can have serious consequences such as aspiration pneumonia, increased lenght of hospitalisation, and death. It would be interesting to enhance the therapeutic effect of swallowing retraining by means on non-invasive brain stimulation such as transcranial direct current stimulation (tDCS). Hypothesis: during the acute phase of stroke, applying tDCS over the brain during the revalidation and/or supervised feeding improves dysphagia significantly when compared to sham tDCS.
Detailed Description
tDCS will be used in a double-blind, randomized control trial in acute stroke patients suffering from dysphagia. After informed consent and recruitment, patients will be randomly (computer method) allocated to real or sham tDCS, that will be applied during swallowing exercices/therapy or supervised feeding. Baseline and follow-up outcomes about dysphagia will be collected.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Stroke, Dysphagia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
tDCS
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
randomisation by computer
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
real tDCS
Arm Type
Active Comparator
Arm Description
patients will receive non-invasive and painless brain stimulation over the rain areas involved in swallowing. tDCS will be applied during swallowing therapy, during 20 minutes
Arm Title
sham tDCS
Arm Type
Placebo Comparator
Arm Description
this will be exactly as for "real tDCS" unless that the tDCS will be rapidly turned off, unbeknown from patients-therapist-examinator (double-blind trial)
Intervention Type
Device
Intervention Name(s)
transcranial direct current stimulation (tDCS)
Other Intervention Name(s)
Eldith PLUS tDCS, NeuroConn, Ilmenau, Germany
Intervention Description
tDCS is a safe and painless transcranial stimulation that modulates brain activity and could improve stroke recovery. Electrodes in soaked sponges are placed over specific brain regions and held with an elastic band. Direct current is then applied through the electrodes. The patients may feel nothing or a slight tingling under the electrodes.
Primary Outcome Measure Information:
Title
VideoFluoroscopy (VFSS)
Description
The patients will be asked to swallow radiocontrast agent liquid during RX (radiography) video-recording. The speed of swallowing, whether there is aspiration or stasis will be quantified off-line on videotape
Time Frame
baseline, end of acute stroke phase, follow up (3, 6, 12 months)
Title
Fiberoptic Endoscopic Evaluation of Swallowing (FEES)
Description
A laryngoscope (attached to a camera and a color monitor) will be passed through the nostril. The patients will be asked to swallow small quantities of liquids and foods, and the quality of swallowing will be assessed off-line (videotaped examination). The base of the tongue, pharynx and larynx will be viewed.
Time Frame
baseline, end of acute stroke phase, follow up (3, 6, 12 months)
Secondary Outcome Measure Information:
Title
NIH Stroke Scale
Description
The NIS Stroke Scale is a clinical scale developped to score the severity of acute stroke. Patients will be asked to make some movements, vision will be tested, whether there are difficult to speak and so on.
Time Frame
baseline, end of acute stroke phase, follow up (3, 6, 12 months)
Title
clinical record
Description
the records of the acute stroke patients will be used to search for relevant clinical events.
Time Frame
baseline, end of acute stroke phase, follow up (3, 6, 12 months)
Title
quality-of-life (QOL) questionnaire designed for dysphagia (SWAL-QOL)
Description
A quality-of-life (QOL) questionnaire specifically designed for patients with oropharyngeal dysphagia (SWAL-QOL) will be used, questions will be asked to the patients / proxies? The French version of the SWAL-QOL will be used
Time Frame
baseline, end of acute stroke phase, follow up (3, 6, 12 months)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: - acute stroke (ischemic / hemorrhagic) with dysphagia Exclusion Criteria: major swallowing impairment before the stroke troubles of comprehension impairing communication major cognitive dysfunction, neuro-degenerative disease, or major psychiatric condition (e.g. depression, Alzheimer's disease, …) very unstable health issue (e.g. severe cardiac dyscfct, end-stage renal failure, unstable diabetes, …) intracranial metal and/or devices excluding tDCS application chronic intake of major drugs modifying brain activity (e.g. AEDs, antipsychotics) regular use of alcohol or recreative drugs epilepsy pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yves Vandermeeren, MD, PhD
Organizational Affiliation
University Hospital of Mont-Godinne
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital of Mont-Godinne : CHU Mont-Godinne UCL
City
Yvoir
State/Province
Namur
ZIP/Postal Code
5530
Country
Belgium

12. IPD Sharing Statement

Learn more about this trial

Improving SWAllowing After Stroke With Transcranial Direct Current Stimulation

We'll reach out to this number within 24 hrs